OSOlaf Strauß

Olaf Strauß

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Olaf Strauß has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Anoctamin‐1 Is a Calcium‐Dependent Chloride Channel ( CaCC ) in Müller Cells Involved in Cell Volume Regulation

    by Alissa Schaefer, Oliver Bludau, Andjela Sekulic, Sena Altunok, Stefan Mergler, Christine von Toerne, Stefanie M. Hauck, Antje Grosche, Olaf Strauß, Nadine Reichhart

    Previous functional data showed the presence of Cl − channels in Müller cells, among them Ca 2+ ‐dependent Cl − channels (CaCC). An important step to understanding the role of CaCC in Müller cell function is the clarification of their molecular identity. Here, we found protein expression of the CaCC anoctamin‐1 (Ano1, formerly TMEM16A) in Müller cells in retinal sagittal sections of mouse and rat using immunohistochemistry and proteomic analysis, as well as in the Müller cell lines ImM10 (murine) and MIO‐M1 (human), accompanied by Western blot. Patch‐clamp analysis of both cell lines under K + ‐free conditions showed the activation of membrane currents through an increase in intracellular free Ca 2+ using either ionomycin, ATP, or adenosine. These currents were sensitive to several blockers: the broad anoctamin blocker niflumic acid, the CaCC blocker CaCCinh‐A01, and the Ano1 blocker T16Ainh‐A01. To further explore the function of Ano1 in Müller cells, we investigated the adenosine‐dependent volume regulation in mouse Müller cells in freshly isolated sagittal sections under hypoosmotic challenge by blockage of K + channels. T16Ainh‐A01 partially reversed the beneficial effect of adenosine on Müller cell volume regulation. We conclude that Ano1 is one of the first functionally validated Cl − channels in Müller cells. Ano1 seems to contribute to the adenosine‐driven regulation of ion flow across the Müller cell membrane, which is crucial for clearing extracellular fluid from the retina.

  • Open Access

    Evaluation of risk promoting effects for age-related macular degeneration by estradiol

    by Inga-Marie Pompös, Dietrich Polenz, Norbert Kociok, Silvia Winkler, Olaf Strauß

    Early menopause increases the risk for age-related macular degeneration (AMD), the most common cause of vision loss in industrialized countries. The supplementation with estradiol reduces the risk in these cases and suggesting that estradiol deficiency is a mediator of the risk association. We investigated rat models of estradiol deficiency mimicking either biological ageing (22 months of age) or early menopause by ovariectomy and age of 22 months. Serum analysis of gonadal hormones in both models showed the expected reduction in estradiol levels compared to 6 months old controls but also increases in progesterone, corticosterone and dehydroepiandrosterone sulfate (DHEA-S). Comparing the two estradiol deficiency models, we found no differences except for DHEA-S that were reduced in ovariectomized rats. The hormone status was associated with degenerative changes in the retina with higher activity of mononuclear phagocytes and p16/p21-dependent senescence. Mainly the estrogen receptor beta (ERβ) expressing cells were affected by estradiol deficiency: ganglion cells, cells of the inner nuclear layer (INL) and retinal pigment epithelial cells. An exception are photoreceptors that were ERβ negative, showed stronger degeneration in ovariectomized rats compared to sham treated animals. We conclude that either biological or ovariectomy induced estradiol deficiency might not cause but rather promote mechanisms that lead to AMD. The phenotype depends on a broader spectrum of altered hormones than on estradiol alone. Photoreceptor degeneration and cellular senescence that were ERβ independent in ovariectomized rats suggest non-estradiol effects to increase AMD risk by early menopause.


  • The Epidemiology and Survival Outcomes of Adult Conjunctival Malignancies in Germany: A Decade-Long Population-Based Analysis (2009–2019)

    by Piotr Chlad, Vinodh Kakkassery, Armin Wolf, Christina V. Miller, Olaf Strauss, Ahmad Samir Alfaar

    PurposeThis study aims to evaluate the epidemiological patterns, treatment strategies, and survival outcomes of conjunctival malignancies in Germany between 2009 and 2019.MethodsA total of 1,532 cases were analyzed, with the crude incidence rate calculated. The survival rates were investigated using life tables and Cox regression analysis.ResultsThe overall incidence rate was 1.7 per million. Incidence rates varied across age groups, peaking in the 75+ age group. Carcinomas (43%), melanomas (30%), and lymphomas (20%), were the most prevalent malignancies. Of the total cases with reported treatment, surgical intervention was undertaken in 64.5% of the patients. The 5-year overall survival rates were 90.4% for lymphomas, 73.8% for melanomas, and 72.9% for carcinomas. Age at diagnosis emerged as a significant prognostic factor in the Cox regression analysis.ConclusionsThis study provides the first population-based incidence data on conjunctival malignancies in Germany, noting a generally low incidence with survival rates comparable to other regions. The findings underscore the importance of consistent reporting and further research into risk factors for a deeper understanding of these malignancies. The study calls for improved reporting systems and further investigations into genetic factors and targeted prevention strategies for high-risk groups.


  • Open Access

    Declining incidence and improving survival of ocular and orbital lymphomas in the US between 1995 and 2018

    by Ahmad Samir Alfaar, Yacoub A. Yousef, Matthew W. Wilson, Omneya Hassanain, Vinodh Kakkassery, Mohanad Moustafa, Ahmad Kunbaz, Amanne Esmael, Olaf Strauß

    This epidemiological study examined ocular and orbital lymphomas in the United States from 1995 to 2018, using data from the North American Association of Central Cancer Registries database of 87,543 patients with ocular and adnexal malignancies. We identified 17,878 patients (20.4%) with ocular and orbital lymphomas, with an age-standardized incidence rate (ASIR) of 2.6 persons per million (ppm). The incidence was the highest in the orbit (ASIR = 1.24), followed by the conjunctiva (ASIR = 0.57). Non-Hodgkin B-cell lymphoma was the most prevalent subtype (85.4%), particularly marginal-zone lymphoma (45.7%). Racial disparities were noted, with Asia–Pacific Islanders showing the highest incidence (orbit, 1.3 ppm). The incidence increased significantly from 1995 to 2003 (Average Percent Change, APC = 2.1%) but declined thereafter until 2018 (APC = − 0.7%). 5-year relative survival (RS) rates varied, with the highest rate for conjunctival lymphoma (100%) and the lowest for intraocular lymphoma (70.6%). Survival rates have generally improved, with an annual increase in the 5-year RS of 0.45%. This study highlights the changing epidemiological landscape, pointing to initial increases and subsequent decreases in incidence until 2003, with survival improvements likely due to advancements in treatment. These findings underscore the need for further research to investigate the root causes of these shifts and the declining incidence of ocular lymphoma.


  • Open Access

    Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body

    by Ahmad Samir Alfaar, Anas M. Saad, Mahmoud Tawfik KhalafAllah, Omneya Ezzat Elsherif, Moataz Hamed Osman, Olaf Strauß

    Purpose: The eye and its adnexal structures can give rise to first or consecutive primary malignancies or to encounter metastasis. Our aim was to define the characteristics of the second primary neoplasms affecting the eye and its adnexa and find the risk modifying factors for them after malignancies elsewhere in the body. Methods: We have queried the Surveillance, Epidemiology and End-Results “SEER”-9 program of the National Cancer Institute for the malignancies of the eye and its adnexa that occurred between 1973 and 2015. The malignancies were ordered chronologically according to their incidence: first or second primary malignancies. The tumors were classified according to ICD-O-3 classification. Standardized incidence ratios (SIR) and survival probabilities were calculated for subgroups. Results: Among 3,578,950 cancer patients, 1203 experienced a second malignancies of the eye and its adnexa. The first malignancy was diagnosed between 50 and 69 years of age in 58.94% of them. The eyelid showed 280 events, while 50 in lacrimal gland, 181 in the orbit, 21 in the overlapping lesions, 15 in optic nerve, 148 in the conjunctiva, 9 in the cornea, 6 in the Retina, 379 in the choroid, and 93 in the ciliary body. The SIR of a second malignancy after a prior non-Hodgkin lymphoma was 2.42, and in case of previous skin carcinomas it was 3.02, melanoma of skin, and 2.13 and 1.58 in oral cavity/pharynx malignancies. The second ocular and adnexal neoplasms increased steadily over the 5-year periods on contrary to first primary neoplasms. The survival of patients affected with first ocular and adnexal neoplasms was significantly higher than those with second ocular and adnexal neoplasms. On the other side, second primary ocular and adnexal tumors showed a better survival than second primary malignancies elsewhere. Conclusions: The epidemiological differences between first and second ocular and adnexal primaries suggest different underlying mechanisms. Careful ocular examination should be integrated in the long-term follow-up plan of cancer patients. Special attention should be given to patients with non-Hodgkin’s lymphoma and melanoma as first primary.


  • Expression profile of voltage-dependent Ca2+ channel subunits in the human retinal pigment epithelium

    by Sönke Wimmers, Linn Coeppicus, Rita Rosenthal, Olaf Strauß

    The secretion of a variety of factors by the retinal pigment epithelium (RPE) is essential for the structural integrity of the neuronal retina and choroid, but also plays a pivotal role in the etiology of diseases such as choroidal neovascularisation. A recent study showed that the secretory activity of the RPE is regulated by the activity of a certain type of voltage-dependent Ca2+ channels, the L-type channel. In order to provide a better base for the understanding of the underlying Ca2+ signalling in these cells, we investigated the expression profile of voltage-dependent Ca2+ channel subunits in RPE cells.